Blackstone, Carlyle, KKR Eye $11 Billion Buyout

Apr 10 2013 | 10:28am ET

A trio of private equity giants are circling laboratory supplies and genetic testing company Life Technologies in what could be among the largest buyouts of the year.

The Blackstone Group, the Carlyle Group and Kohlberg Kravis Roberts, along with Singapore's sovereign wealth fund, are preparing an $11 billion bid for Life. The four were in talks late last night on terms, even after the deadline for bids passed. Should the private equity group manage to find the needed equity, Life would likely accept a bid after the deadline, according to Reuters.

The p.e. group will have to compete with a bid from Thermo Fisher Scientific, which submitted its offer yesterday.

The p.e. group as it exists is actually a merger of what could have been two competing consortia: Blackstone, Carlyle and Temasek Holdings had been working with TPG Capital, which has since dropped out, while KKR was working on a deal with other partners, who also backed out.


In Depth

Debunking Conventional Investment Wisdom

Feb 8 2017 | 3:22pm ET

Due diligence in the hedge fund world has long involved some combination of the...

Lifestyle

'Tis the Season: Wall Street Holiday Parties Back In Fashion

Dec 22 2016 | 9:23pm ET

Spending on Wall Street holiday parties has largely returned to pre-2008 levels...

Guest Contributor

iCapital Network: The Trump Effect On Direct Lending

Feb 23 2017 | 4:21pm ET

The arrival of the Trump Administration has raised questions among private debt...

 

From the current issue of